Making Vaccines: How Are Vaccines Made?
Several basic strategies are used to make vaccines. The strengths and limitations of each approach are described here.
Weaken the virus
Using this strategy, viruses are weakened so they reproduce very poorly once inside the body. The vaccines for measles, mumps, German measles (rubella), rotavirus, oral polio (not used in the U.S.), chickenpox (varicella), and influenza (intranasal version) vaccines are made this way. Viruses usually cause disease by reproducing themselves many times in the body. Whereas natural viruses reproduce thousands of times during an infection, vaccine viruses usually reproduce fewer than 20 times. Because vaccine viruses don't reproduce very much, they don't cause disease, but vaccine viruses replicate well enough to induce "memory B cells" that protect against infection in the future. Find out more about these and other cells of the immune system.
The advantage of live, "weakened" vaccines is that one or two doses provide immunity that is usually life-long. The limitation of this approach is that these vaccines usually cannot be given to people with weakened immune systems (like people with cancer or AIDS). Find out more about what happens when the immune system doesn’t work properly.
Inactivate the virus
Using this strategy, viruses are completely inactivated (or killed) with a chemical. By killing the virus, it cannot possibly reproduce itself or cause disease. The inactivated polio, hepatitis A, influenza (shot), and rabies vaccines are made this way. Because the virus is still "seen" by the body, cells of the immune system that protect against disease are generated.
There are two benefits to this approach:
- The vaccine cannot cause even a mild form of the disease that it prevents
- The vaccine can be given to people with weakened immune systems
However, the limitation of this approach is that it typically requires several doses to achieve immunity.
Use part of the virus
Using this strategy, just one part of the virus is removed and used as a vaccine. The hepatitis B, shingles, and human papillomavirus (HPV) vaccines are made this way. The vaccine is composed of a protein that resides on the surface of the virus. This strategy can be used when an immune response to one part of the virus (or bacteria) is responsible for protection against disease.
These vaccines can be given to people with weakened immunity and appear to induce long-lived immunity after two doses.
Use part of the bacteria
Some bacteria cause disease by making a harmful protein called a toxin. Several vaccines are made by taking toxins and inactivating them with a chemical (the toxin, once inactivated, is called a toxoid). By inactivating the toxin, it no longer causes disease. The diphtheria, tetanus and pertussis vaccines are made this way.
Another strategy to make a bacterial vaccine is to use part of the sugar coating (or polysaccharide) of the bacteria. Protection against infection by certain bacteria is based on immunity to this sugar coating (and not the whole bacteria). However, because young children don't make a very good immune response to the sugar coating alone, the coating is linked to a harmless protein (this is called a "conjugated polysaccharide" vaccine). The Haemophilus influenzae type B (or Hib), pneumococcal, and some meningococcal vaccines are made this way.
Two meningococcal vaccines, which prevent one particular type of the bacterium (type B) not contained in the other meningococcal vaccines, are made using two or more proteins from the bacteria, not the bacterial polysaccharide.
Just like for inactivated viral vaccines, bacterial vaccines can be given to people with weakened immune systems, but often require several doses to induce adequate immunity.
Provide the genetic code (DNA, mRNA, or vectored viruses) for part of the virus
Using this strategy, the person who is vaccinated makes part of the virus. The vaccines for COVID-19 are made this way. The vaccine contains messenger RNA (mRNA), which is the code, or blueprint, for the spike protein of the SARS-CoV-2 virus. The vaccinated person’s muscle cells use the blueprint to make the spike protein from the surface of the virus. Once the immune system realizes this protein is “foreign,” it creates an immune response against it, including immunologic memory, so the next time, the person is exposed to the virus, the immune system is ready to respond rapidly. Similar to vaccination strategies that inject parts of a virus directly, this strategy can be used when an immune response to one part of the virus is capable of protecting against disease.
These vaccines can be given to people that are immune-compromised but require two doses to be protective.
DNA vaccines deliver the genetic code from which mRNA is made. The mRNA then serves as the blueprint for making the viral protein, and the immune system, recognizing it is “foreign,” responds to protect the body and create immunologic memory. Currently, no DNA vaccines are commercially available.
Another way to deliver the gene that codes for the coronavirus spike protein is to put that gene into a virus that can’t reproduce itself but can still enter cells and deliver the needed gene. This strategy is being used in so-called replication-deficient human or simian adenoviruses. Although adenoviruses can cause disease in people, these vectored viruses are engineered so that they can’t cause disease.
Materials in this section are updated as new information and vaccines become available. The Vaccine Education Center staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family's personal health. You should not use it to replace any relationship with a physician or other qualified healthcare professional. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult your physician or, in serious cases, seek immediate assistance from emergency personnel.